Testing effectiveness (Phase 2)Study completedNCT00425204
What this trial is testing
Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment
Who this might be right for
Colorectal CancerNon-Small Cell Lung CancerProstate Cancer+2 more
Amgen 31